Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nortriptyline vs Paroxetine for Depression in Parkinson's Disease
NCT00062738Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Jun 2003
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Nortriptyline, Paroxetine and Placebo (3 arms). Primary endpoint: Hamilton Depression Scale at 8 weeks. Started Jun 2003; status: completed.
02
Drugs
nortriptylineparoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00062738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062738.